Literature DB >> 8627998

Long-term outcome after pneumonectomy for nonsmall cell lung cancer.

P M Rocco1, J G Antkowiak, H Takita, J D Urschel.   

Abstract

Long-term survivors (5 or more years) of pneumonectomy for nonsmall cell lung cancer are at risk for late death from cancer recurrence, second primary malignancies, and cardiopulmonary insufficiency related to the adverse physiological effects of pneumonectomy. A retrospective study of pneumonectomy patients was done to quantify the risks of late death from these causes. Of 246 patients treated for nonsmall cell lung cancer by pneumonectomy, medical records of 49 who survived 5 or more years were reviewed. Follow-up for the 49 long-term survivors ranged from 60 to 240 months, with a mean of 113 months. Twenty-five (51%) of the long-term survivors were alive at the time of the study. Twenty-four (49%) had died. Causes of death included late lung cancer recurrence (6 patients), second primary malignancies (7 patients), cardiopulmonary insufficiency (4 patients), and miscellaneous causes unrelated to cancer and its treatment (7 patients). Long-term survival after pneumonectomy for nonsmall cell lung cancer occurs in 20% of patients. Late lung cancer recurrence and second primary malignancies are important causes of death in these patients. Late cardiopulmonary insufficiency related to adverse physiological consequences of pneumonectomy is uncommon. Long-term follow-up is recommended after pneumonectomy for nonsmall cell lung cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8627998     DOI: 10.1002/(SICI)1096-9098(199604)61:4<278::AID-JSO9>3.0.CO;2-7

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  2 in total

1.  Extended bronchoplasty and angioplasty with a right upper-middle bilobectomy and S6 segmentectomy for lung cancer: a novel technique for anastomosis.

Authors:  Mitsuhiro Kamiyoshihara; Takashi Ibe; Izumi Takeyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-06-17

2.  Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT.

Authors:  J Nakano; C Huang; D Liu; D Masuya; T Nakashima; H Yokomise; M Ueno; H Wada; M Fukushima
Journal:  Br J Cancer       Date:  2006-08-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.